Pharmaceutical company [UNK] Biopharma has raised $ 100 m in a seed round led by Huagai and backed by investors including OncoCapital and Yingke . Count Hai­He Bio­phar­ma in the new gen­er­a­tion of Chi­nese biotechs an­swer­ing the clar­i­on call for home­grown in­no­va­tion. The firm is also supported by Hillhouse Capital , China Pharma and the Chinese Academy of Science ’s venture division . Most of the funding will be used to develop the firm ’s clinical and preclinical trial programs . It has already won approval for more than 12 trials . HaiHe joined forces with RMX Biopharma in March 2018 .
Pharmaceutical company [UNK] Biopharma has raised $ 100 m in a seed round led by Huagai and backed by investors including OncoCapital and Yingke . The firm is also supported by Hillhouse Capital , China Pharma and the Chinese Academy of Science ’s venture division . Most of the funding will be used to develop the firm ’s clinical and preclinical trial programs . It has already won approval for more than 12 trials . HaiHe joined forces with RMX Biopharma in March 2018 .